drugset / Trial / NCT00111891
An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032)
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a 3-week trial in normal healthy or lipid clinic patients studying a novel approach to treating dyslipidemia.
Timeline
- Start
- 2005-06
- Primary completion
- 2005-08
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Niacin | Small molecule | — | — |
| Subject | laropiprant | Small molecule | — | — |